Live Quote · NASDAQARWRHealthcare· Biotechnology

Arrowhead Pharmaceuticals, Inc.

$41.37▼ 5.22%($-2.28)
MKT CAP $5.85BNEXT EARNINGS Feb 4, 2027
50%
Bullish
TickerSpark Score
33/100
▌ Poor
27
Valuation
40
Profitability
10
Growth
56
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARWR research report →

Analyst Price Target
$111.20+168.8% vs. today

Range $74 – $126

Analyst RatingBuy
16 Buy6 Hold0 Sell

Price Chart

+12.50% · this period
$89.59$63.84$38.09Nov 20May 26Nov 20
52-Week Range7% of range
Low
$37.43
Current
$41.37
High
$95.49

AI analysis · Last refreshed November 14, 2026 · Live quote · Not investment advice